These 2 Coronavirus Stocks Could Soar in the Second Half of 2020
Moderna (NASDAQ: MRNA) and Vaxart (NASDAQ: VXRT) are two of the many companies that are pursuing a COVID-19 vaccine. The stock market has already produced a lot of riches for biotech investors in this sector; Moderna's stock has almost quadrupled in six months, while the stock of tiny Vaxart has produced an amazing 2,985% return in that time.
Can these two stocks continue to advance? Both companies will be giving data readouts in the second half of 2020. Positive data will no doubt cause stock prices to double, triple, or quadruple once again. But bad news could cause either stock to implode. Let's dig in and see what we might expect.
Source Fool.com